about
Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future researchHistorical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter studyComputerized EEG topography findings in schizophrenic patients before and after haloperidol treatmentNeurobiological background of negative symptoms.EEG microstate duration and syntax in acute, medication-naive, first-episode schizophrenia: a multi-center study.Shall we really say goodbye to first rank symptoms?Is avolition in schizophrenia associated with a deficit of dorsal caudate activity? A functional magnetic resonance imaging study during reward anticipation and feedback.Toward a new definition of mental healthThe status of spectral EEG abnormality as a diagnostic test for schizophreniaPatterns of structural MRI abnormalities in deficit and nondeficit schizophrenia.Deficit schizophrenia: an overview of clinical, biological and treatment aspects.Schizophrenia--time to commit to policy change.Primary and persistent negative symptoms: Concepts, assessments and neurobiological bases.Reward anticipation and trait anhedonia: An electrophysiological investigation in subjects with schizophrenia.The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia.Pathways to functional outcome in subjects with schizophrenia living in the community and their unaffected first-degree relatives.The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study.Attitudes of patients with schizophrenia and depression to psychiatric research: a study in seven European countries.SoCIAL - training cognition in schizophrenia: a pilot study.Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairment.Cognitive-enhancing effects of aripiprazole: a case report.Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST).Ala147Thr substitution in translocator protein is associated with adult separation anxiety in patients with depression.Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study.Unmet needs in patients with first-episode schizophrenia: a longitudinal perspective.Impulsiveness in patients with bulimia nervosa: electrophysiological evidence of reduced inhibitory control.Neurocognitive functioning in subjects with eating disorders: the influence of neuroactive steroids.Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia.Lateralization patterns of verbal stimuli processing assessed by reaction time and event-related potentials in schizophrenic patients.Factors associated with decreased platelet MAO activity in chronic schizophrenics.Neurocognitive functioning in bulimia nervosa: the role of neuroendocrine, personality and clinical aspects.Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST).Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study.Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.Frequency and clinical correlates of adult separation anxiety in a sample of 508 outpatients with mood and anxiety disorders.Characterization of premorbid functioning during childhood in patients with deficit vs. non-deficit schizophrenia and in their healthy siblings.Modified nutritional counselling to increase motivation to treatment in anorexia nervosa.Editorial: The EPA, Brexit and beyond.Dissecting negative symptoms of schizophrenia: History, assessment, pathophysiological mechanisms and treatment.The Brief Negative Symptom Scale (BNSS): Independent validation in a large sample of Italian patients with schizophrenia.
P50
Q28082090-9144D85F-38E4-4406-89AE-21FCA6B36849Q28202039-8D0F37B8-46D3-453F-82F3-E516CB6BFA6FQ28317700-4753824F-9B5A-4B6F-A04A-EC0572EEA33EQ30913824-8F4E4E6D-1672-4F3D-A73D-5204A2AA5F2DQ31153575-94D14D03-D75A-4C7D-A897-87ED4A50C8DCQ34534424-3C37B532-1319-49B8-90AC-CC2110E3CC31Q35559267-60AD2010-2FC5-44AC-972D-F47D00779984Q35754766-13FE0FDB-6C86-4362-A65A-2DC41CBE0C12Q36528917-F6778F37-8CFE-4DCC-8029-4BB393329B3BQ37076288-AC5055C3-E231-4CFA-A55B-77C269BB5E80Q37530030-AD822DC1-F1F0-49B2-9CC7-406BABB9878DQ37727560-EF92F134-4EC7-49DF-8458-91877C485FE2Q38848808-6AF2906E-92CB-45B9-8E0E-4DB2C507AC45Q38911134-A75F76C1-E0F9-4A1D-812C-CE49096077D0Q39269381-C8898F08-3C97-4436-92A2-0497E943EE5CQ39291255-E941B077-EC60-4BCA-B597-A02CBB558C56Q39293378-61D7D093-E54A-4C1B-85B4-962E44778F23Q39904748-38E6BE46-0550-4254-8AA3-E9F4E68BCFD5Q41144296-7626EA1E-F0D1-4F32-A9C7-2E56BF6B3A7BQ42663078-15AF6A94-B937-449E-9BB6-9453C1C7C3FDQ43242343-E314F4A6-7FBD-45B8-AFB0-861A0B0318FCQ43264112-D7C2DCCC-1445-427B-8ECE-DC4FF2A49FB8Q43294897-947B4C9F-AB12-4246-9631-270615CF1928Q43990949-06EA0845-4E89-450A-B148-D390B9B2A037Q44351410-3909737E-6108-4728-9112-5A64E6D8EFDAQ44376957-EA275914-22E3-4C55-AB8C-C2AB628E5FF2Q44438244-297C0EE0-1308-4CE2-B6E5-02158DFE03FEQ44563200-32615818-C766-4454-B675-55917B362AD7Q44636424-E7F40D7C-DAA1-4A14-BA51-2506E829ED9AQ45819128-B3136CB4-4AAE-4A2E-9C8D-38972662C6BDQ45932710-577DA61B-C14A-41CC-B423-FA68FC31EDAFQ46049842-5E67FDBB-81F9-4615-98AA-B8917C815517Q46385705-35F0A714-F422-4EA6-B8DE-74CAA6D7C68BQ46675364-E4F08B09-41A6-45C2-938C-9F768E50C3CFQ46918235-6A530235-4E14-4F1F-A561-192387A18528Q47590015-EBF8BBF8-2F84-46AF-A93C-EC5E2F647BB0Q47619657-2334C067-6D19-4E0E-A172-961A82256CACQ47801265-96DC3826-06A6-45C7-AF9E-54A037887593Q48022778-FC955EA7-35B3-42D3-B5E8-09D102958807Q48099121-2E424FE1-0EDF-4F57-899E-61A8D73DB019
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Silvana Galderisi
@ast
Silvana Galderisi
@en
Silvana Galderisi
@es
Silvana Galderisi
@nl
Silvana Galderisi
@sl
type
label
Silvana Galderisi
@ast
Silvana Galderisi
@en
Silvana Galderisi
@es
Silvana Galderisi
@nl
Silvana Galderisi
@sl
prefLabel
Silvana Galderisi
@ast
Silvana Galderisi
@en
Silvana Galderisi
@es
Silvana Galderisi
@nl
Silvana Galderisi
@sl
P106
P1153
7003306444
P2038
Silvana_Galderisi
P21
P214
30150868194722071442
P31
P496
0000-0002-1592-7656
P735
P7859
viaf-30150868194722071442